Our research pipeline is rich with transformational science reflecting our unique approach to innovation. See More > R&D Data Science Using data science and digital health to reimagine the discovery and development of medicines to advance our mission of bringing transformative therapies to patients...
Learn more below about our pipeline, as well as our efforts to help raise awareness of the importance of combating infectious diseases with innovative medicines and vaccines.Penny Heaton, M.D. Global Therapeutic Area Head, Vaccines James Merson, Ph.D. Global Therapeutic Area Head, Infectious ...
Financial details of the deal have not been disclosed and will add Hemera’s gene therapy HMR59 to Janssen’s pipeline of ophthalmology drugs. The privately-held biotech has developed the gene therapy as a single shot to treat dry age-related macular degeneration, or dry AMD. In the form of...
“Understanding the needs of the patient starts very early on in the development process,” says Capperella. “We have to understand the unmet needs of patients in order to prioritize our pipeline accordingly. Then, once we have a specific compound prioritized in our pipeline, our effort becom...
“Our robust and diverse pipeline is built around the synergy that emerges from approaching cancer from different angles simultaneously, and through open and continuous innovation,” said Lebowitz. “Our ultimate goal is to eliminate cancer by delivering transformational regimens to achieve cures and/or...
(NK) cell product pipeline and has elected to focus on advancing its most innovative and differentiated programs, which have a multiplexed-engineered cellular framework of novel synthetic controls designed to promote multi-antigen targeting, increase potency, extend functional persistence, ...
La Merie Publishing offers the service of preparing customized reports tailored to the needs and specifications of the customer. We conduct scientific & medical literature evaluations for clients of the biopharmaceuti...
M.D., Ph.D., Executive Vice President, Chief External Innovation and Medical Officer and Interim Head, Janssen R&D. “We remain focused on advancing our differentiated pipeline, improving the lives of millions of patients and developing new modalities in areas with the greatest unmet medical need...
M.D., Ph.D., Executive Vice President, Chief External Innovation and Medical Officer and Interim Head, Janssen R&D. “We remain focused on advancing our differentiated pipeline, improving the lives of millions of patients and developing new modalities in areas with the greatest unmet medical need...
Manage My Portfolio Portfolio Health Check Privacy Alert Preferences Subscriptions Premium & Pro About Premium Group Subscriptions Alpha Picks About Alpha Picks FREE Newsletters Investing Groups Learn About Investing Groups Most Popular Free Trials Top Rated Dividend Investing Value Investing Options ...